Serum inflammatory molecules and markers of neuronal damage in alcohol-dependent subjects after withdrawal

References

• Achur RN, Freeman WM, Vrana KE. 2010. Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol. 5:83–91.
   PubMed Web of Science ®Google Scholar
• Aguiar-Nemer AS, Toffolo MC, da Silva CJ, Laranjeira R, Silva-Fonseca VA. 2013. Leptin influence in craving and relapse of alcoholics and smokers. J Clin Med Res. 5:164–167.
   PubMedGoogle Scholar
• Anton RF, Moak DH, Latham P. 1995. The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism Clin Exp Res. 19:92–99.
   PubMed Web of Science ®Google Scholar
• Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. 2001. The Alcohol Use Disorders Identification Test, Guidelines for Use in Primary Care. Second Edition (WHO/MSD/MSB/01.6a). Department of Mental Health and Substance Dependence, World Health Organization, Geneva, Switzerland.
   Google Scholar
• Bell S, Mehta G, Moore K, Britton A. 2017. Ten-year alcohol consumption typologies and trajectories of C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist over the following 12 years: a prospective cohort study. J Intern Med. 281:75–85.
   PubMed Web of Science ®Google Scholar
• Berridge KC. 1996. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 20:1–25.
   PubMed Web of Science ®Google Scholar
• Brin T, Borucki K, Ambrosch A. 2011. The influence of experimental alcohol load and alcohol intoxication on S100B concentrations. Shock. 36:356–360.
   PubMed Web of Science ®Google Scholar
• Cacabelos R, Torrellas C, Fernández-Novoa L, López-Muñoz F. 2016. Histamine and Immune Biomarkers in CNS Disorders. Mediators Inflamm. 2016:1924603.
   PubMedGoogle Scholar
• Cahill PA, Redmond EM. 2012. Alcohol and cardiovascular disease-modulation of vascular cell function. Nutrients. 4:297–318.
   PubMed Web of Science ®Google Scholar
• Calcagnile O, Holmén A, Chew M, Undén J. 2013. S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury. Scand J Trauma Resusc Emerg Med. 21:52.
   PubMed Web of Science ®Google Scholar
• Cardoso Fernandes Toffolo M, Aparecida Marliére C, Nascimento de Freitas S, Silva de Aguiar Nemer A. 2012. Increasing leptin level in abstaining alcohol-dependent women. Nutr Hosp. 27:781–788.
   PubMed Web of Science ®Google Scholar
• Chignon JM, Jacquesy L, Mennad M, Terki A, Huttin F, Martin P, Chabannes JP0. 1998. Self-assessment of alcoholic craving: validation of the French version of the obsessive compulsive drinking scale (OCDS). L' Encéphale. 24:426–434.
   PubMed Web of Science ®Google Scholar
• Cirillo C, Sarnelli G, Esposito G, Turco F, Steardo L, Cuomo R. 2011. S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. World J Gastroenterol. 17:1261–1266.
   PubMed Web of Science ®Google Scholar
• Collet L, Cottraux J. 1986. Inventaire abrégé de la dépression de Beck (13 items). Etude de la validité concurrente avec les échelles de Hamilton et de ralentissement de Widlcher. L'Encéphale. 12:77–79.
   PubMedGoogle Scholar
• Conde J, Scotece M, Abella V, López V, Pino J, Gómez-Reino JJ, Gualillo O. 2014. An update on leptin as immunomodulator. Expert Rev Clin Immunol. 10:1165–1170.
   PubMed Web of Science ®Google Scholar
• Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J. 2006. Cytokines and alcohol. Alcohol Clin Exp Res. 30:720–730.
   PubMed Web of Science ®Google Scholar
• Crews FT, Lawrimore CJ, Walter TJ, Coleman LG Jr. 2017. The role of neuroimmune signaling in alcoholism. Neuropharmacology. S0028-3908:30037–30030.
   Google Scholar
• de Timary P, Stärkel P, Delzenne NM, Leclercq S. 2017. A role for the peripheral immune system in the development of alcohol use disorders? Neuropharmacology. 122:148–160.
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE. 2009. Monocyte Chemoattractant Protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 29:313–326.
   PubMed Web of Science ®Google Scholar
• Donnadieu-Rigole H, Mura T, Portales P, Duroux-Richard I, Bouthier M, Eliaou JF, Perney P, Apparailly F. 2016. Effects of alcohol withdrawal on monocyte subset defects in chronic alcohol users. J Leukoc Biol. 100:1191–1199.
   PubMed Web of Science ®Google Scholar
• Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A. 2015. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 37:223–236.
   PubMed Web of Science ®Google Scholar
• Franchi S, Sacerdote P, Moretti S, Gerra G, Leccese V, Tallone MV, Panerai AE, Somaini L. 2010. The effects of alcoholism pharmacotherapy on immune responses in alcohol-dependent patients. Int J Immunopathol Pharmacol. 23:847–855.
   PubMed Web of Science ®Google Scholar
• Gaydos J, McNally A, Guo R, Vandivier RW, Simonian PL, Burnham EL. 2016. Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells. Am J Physiol Lung Cell Mol Physiol. 310:L507–L518.
   PubMed Web of Science ®Google Scholar
• Gano A, Doremus-Fitzwater TL, Deak T. 2016. Sustained alterations in neuroimmune gene expression after daily, but not intermittent, alcohol exposure. Brain Res. 1646:62–72.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quintela A, Campos J, Loidi L, Quinteiro C, Perez LF, Gude F. 2008. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol. 42:513–518.
   PubMed Web of Science ®Google Scholar
• Gorky J, Schwaber J. 2016. The role of the gut-brain axis in alcohol use disorders. Prog Neuropsychopharmacol Biol Psychiatry. 65:234–241.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol. 32:50–55.
   PubMed Web of Science ®Google Scholar
• Haorah J, Knipe B, Gorantla S, Zheng J, Persidsky Y. 2007. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release. J Neurochem. 100:324–336.
   PubMed Web of Science ®Google Scholar
• Haorah J, Schall K, Ramirez SH, Persidsky Y. 2008. Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: Novel mechanism for neurodegeneration associated with alcohol abuse. Glia. 56:78–88.
   PubMed Web of Science ®Google Scholar
• Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y. 2008. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med. 45:1542–1450.
   PubMed Web of Science ®Google Scholar
• He J, Crews FT. 2008. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol. 210:349–358.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Käser M, Lichtinghagen R, Rhein M, Lenz B, Kornhuber J, Bleich S, Hillemacher T. 2014. TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients? Alcohol. 48:671–676.
   PubMed Web of Science ®Google Scholar
• Hong H, Kim BS, Im HI. 2016. Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int Neurourol J. 20:S2–S7.
   PubMed Web of Science ®Google Scholar
• Hurtado-Alvarado G, Domínguez-Salazar E, Pavon L, Velázquez-Moctezuma J, Gómez-González B. 2016. Blood-brain barrier disruption induced by chronic sleep loss: low-grade inflammation may be the link. J Immunol Res. 2016:4576012.
   PubMedGoogle Scholar
• Keary TA, Gunstad J, Neal DJ, Spitznagel MB, Glickman E, Juvancic-Heltzel J, Alexander T. 2008. Light to moderate alcohol consumption is associated with S100beta and amyloid beta levels in healthy older adults. Exp Aging Res. 34:101–113.
   PubMed Web of Science ®Google Scholar
• Kenna GA, Swift RM, Hillemacher T, Leggio L. 2012. The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans. Neuropsychol Rev. 22:211–228.
   PubMed Web of Science ®Google Scholar
• Kiefer F, Jahn H, Jaschinski M, Holzbach R, Wolf K, Naber D, Wiedemann K. 2001. Leptin: a modulator of alcohol craving? Biol. Psychiatry. 49:782–787.
   PubMed Web of Science ®Google Scholar
• Kiefer F, Jahn H, Kellner M, Naber D, Wiedemann K. 2001. Leptin as a possible modulator of craving for alcohol. Arch Gen Psychiatry. 58:509–510.
   PubMed Web of Science ®Google Scholar
• Kiefer F, Jahn H, Otte C, Demiralay C, Wolf K, Wiedemann K. 2005. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res. 39:545–551.
   PubMed Web of Science ®Google Scholar
• Kraus T, Reulbach U, Bayerlein K, Mugele B, Hillemacher T, Sperling W, Kornhuber J, Bleich S. 2004. Leptin is associated with craving in females with alcoholism. Addict Biol. 9:213–219.
   PubMed Web of Science ®Google Scholar
• Lacagnina MJ, Rivera PD, Bilbo SD. 2017. Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology. 42:156–177.
   PubMed Web of Science ®Google Scholar
• Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. 2007. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom. 72:408–415.
   PubMedGoogle Scholar
• Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. 2007. Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res. 31:846–854.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Cani PD, Neyrinck AM, Stärkel P, Jamar F, Mikolajczak M, Delzenne NM, de Timary P. 2012. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects. Brain Behav Immun. 26:911–918.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, et al. 2014. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 111:E4485–4493.
   PubMed Web of Science ®Google Scholar
• Leclercq S, de Timary P, Delzenne NM, Stärkel P. 2017. The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry. 7:e1048.
   PubMed Web of Science ®Google Scholar
• Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Yu AC. 2011. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer’s disease. Curr Alzheimer Res. 8:67–80.
   PubMed Web of Science ®Google Scholar
• Liappas I, Tzavellas EO, Kariyannis C, Piperi C, Schulpis C, Papassotiriou I, Soldatos CR. 2006. Effect of alcohol detoxification on serum S-100B levels of alcohol-dependent individuals. In Vivo. 20:675–680.
   PubMed Web of Science ®Google Scholar
• Lyons CL, Kennedy EB, Roche HM. 2016. Metabolic Inflammation-Differential Modulation by Dietary Constituents. Nutrients. 8:E247.
   PubMed Web of Science ®Google Scholar
• Mainardi M, Pizzorusso T, Maffei M. 2013. Environment, leptin sensitivity, and hypothalamic plasticity. Neural Plast. 2013:438072.
   PubMed Web of Science ®Google Scholar
• Marshall SA, Geil CR, Nixon K. 2016. Prior Binge Ethanol Exposure Potentiates the Microglial Response in a Model of Alcohol-Induced Neurodegeneration. Brain Sci. 6:E16.
   PubMed Web of Science ®Google Scholar
• Miguel-Hidalgo JJ. 2009. The role of glial cells in drug abuse. Curr Drug Abuse Rev. 2:72–82.
   PubMedGoogle Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382–389.
   PubMed Web of Science ®Google Scholar
• Neupane SP, Lien L, Martinez P, Aukrust P, Ueland T, Mollnes TE, Hestad K, Bramness JG. 2014. High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders. CNS Neurosci Ther. 20:898–904.
   PubMed Web of Science ®Google Scholar
• Neupane SP, Skulberg A, Skulberg KR, Aass HC, Bramness JG. 2016. Cytokine changes following acute ethanol intoxication in healthy men: a crossover study. Mediators Inflamm. 2016:3758590.
   PubMed Web of Science ®Google Scholar
• Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, et al. 2017. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp Mol Pathol. 102:162–180.
   PubMed Web of Science ®Google Scholar
• Nicolás JM, Fernández-Solà J, Fatjó F, Casamitjana R, Bataller R, Sacanella E, Tobías E, Badía E, Estruch R. 2001. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res. 25:83–88.
   PubMed Web of Science ®Google Scholar
• Nikou T, Ioannidis A, Zoga M, Tzavellas E, Paparrigopoulos T, Magana M, Pliatsika P, Nikolaou C, Chatzipanagiotou S. 2016. Alteration in the concentrations of Interleukin-7 (IL-7), Interleukin-10 (IL-10) and Granulocyte Colony Stimulating Factor (G-CSF) in alcohol-dependent individuals without liver disease, during detoxification therapy. Drug Alcohol Depend. 163:77–83.
   PubMed Web of Science ®Google Scholar
• O'Connell K, Thakore J, Dev KK. 2013. Levels of S100B are raised in female patients with schizophrenia. BMC Psychiatry. 13:146.
   PubMed Web of Science ®Google Scholar
• O'Halloran EB, Curtis BJ, Afshar M, Chen MM, Kovacs EJ, Burnham EL. 2016. Alveolar macrophage inflammatory mediator expression is elevated in the setting of alcohol use disorders. Alcohol. 50:43–50.
   PubMed Web of Science ®Google Scholar
• Pascual M, Baliño P, Aragón CM, Guerri C. 2015. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2. Neuropharmacology. 89:352–359.
   PubMed Web of Science ®Google Scholar
• Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min S, Kurt-Jones EA, Szabo G. 2012. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 122:3476–3489.
   PubMed Web of Science ®Google Scholar
• Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D. 2010. Extracranial sources of S100B do not affect serum levels. PLoS One. 5:e12691.
   Google Scholar
• Qi LY, Xiu MH, Chen DC, Wang F, Kosten TA, Kosten TR, Zhang XY. 2009. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics. Neurosci Lett. 462:113–117.
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Arolt V, Bayer TA. 2001. Review of immunological and immunopathologique findings in schizophrenia. Brain Behav Immun. 15:319–339.
   PubMed Web of Science ®Google Scholar
• Schon HT, Weiskirchen R. 2016. Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. Front Pharmacol. 30:283.
   Google Scholar
• Schroeter ML, Sacher J, Steiner J, Schoenknecht P, Mueller K. 2013. Serum S100B represents a new biomarker for mood disorders. Curr Drug Targets. 14:1237–1248.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Agrawal S, Annis H, Ayala-Velazquez H, Echeverria L, Leo GI, Rybakowski JK, Sandahl C, Saunders B, Thomas S, et al. 2001. Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations. Subst Use Misuse. 36:313–331.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Maisto SA, Sobell MB, Cooper AM. 1979. Reliability of alcohol abusers' self-reports of drinking behavior. Behav Res Ther. 17:157–160.
   PubMed Web of Science ®Google Scholar
• Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant'Anna M, Kawamoto SY, Galvão E, Parker G, Fleck MP. 2014. Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure. Neuropsychiatr Dis Treat. 10:1523–1531.
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Zahr NM. 2008. Neuroinflammation as a neurotoxic mechanism in alcoholism: commentary on “Increased MCP-1 and microglia in various regions of human alcoholic brain”. Exp. Neurol. 213:10–17.
   PubMed Web of Science ®Google Scholar
• Szabo G, Lippai D. 2014. Converging actions of alcohol on liver and brain immune signaling. Int. Rev. Neurobiol. 118:359–380.
   PubMed Web of Science ®Google Scholar
• Szabo G. 1999. Consequences of alcohol consumption on host defence. Alcohol Alcohol. 34:830–841.
   PubMed Web of Science ®Google Scholar
• Torrente MP, Freeman WM, Vrana KE. 2012. Protein biomarkers of alcohol abuse. Expert Rev Proteomics. 9:425–436.
   PubMed Web of Science ®Google Scholar
• Umhau JC, Schwandt M, Solomon MG, Yuan P, Nugent A, Zarate CA, Drevets WC, Hall SD, George DT, Heilig M. 2014. Cerebrospinal fluid monocyte chemoattractant protein-1 in alcoholics: support for a neuroinflammatory model of chronic alcoholism. Alcohol Clin Exp Res. 38:1301–1306.
   PubMed Web of Science ®Google Scholar
• Voican CS, Njiké-Nakseu M, Boujedidi H, Barri-Ova N, Bouchet-Delbos L, Agostini H, Maitre S, Prévot S, Cassard-Doulcier AM, Naveau S, et al. 2015. Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease. Liver Int. 35:967–978.
   PubMed Web of Science ®Google Scholar
• Wedekind D, Neumann K, Falkai P, Malchow B, Engel KR, Jamrozinski K, Havemann-Reinecke U. 2011. S100B and homocysteine in the acute alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci. 261:133–138.
   PubMed Web of Science ®Google Scholar
• Yang JY, Xue X, Tian H, Wang XX, Dong YX, Wang F, Zhao YN, Yao XC, Cui W, Wu CF. 2014. Role of microglia in ethanol-induced neurodegenerative disease: Pathological and behavioral dysfunction at different developmental stages. Pharmacol Ther. 144:321–337.
   PubMed Web of Science ®Google Scholar